Refractory Lymphomas Recruiting Phase 2 Trials for Trastuzumab (DB00072)
Also known as: Refractory Lymphoma
Indication | Status | Phase |
---|---|---|
DBCOND0042145 (Refractory Lymphomas) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|
Also known as: Refractory Lymphoma
Indication | Status | Phase |
---|---|---|
DBCOND0042145 (Refractory Lymphomas) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|